Provided by Tiger Trade Technology Pte. Ltd.

Biogen

217.71
-0.7900-0.36%
Volume:234.31K
Turnover:51.04M
Market Cap:32.14B
PE:38.67
High:218.89
Open:216.47
Low:213.58
Close:218.50
52wk High:222.85
52wk Low:133.53
Shares:147.64M
Float Shares:147.31M
Volume Ratio:0.53
T/O Rate:0.16%
Dividend:- -
Dividend Rate:- -
EPS(TTM):5.63
EPS(LYR):8.79
ROE:4.58%
ROA:5.21%
PB:1.71
PE(LYR):24.77

Loading ...

GUIDANCE: (BIIB) Biogen Expects 2026 Adjusted EPS Range $12.00 to $13.00, vs. FactSet Est of $12.63

MT Newswires Live
·
Jul 29

Biogen Q2 Revenue Beats Expectations on Strong Product Demand

Reuters
·
Jul 29

Earnings Flash (BIIB) Biogen Posts Q2 Total Revenue $2.74B, vs. FactSet Est of $2.46B

MT Newswires Live
·
Jul 29

Biogen Q2 Adj. EPS $3.60 Beats $2.96 Estimate, Sales $2.736B Beat $2.458B Estimate

Benzinga Earnings
·
Jul 29

Biogen lowers FY26 EPS view to $12.00-$13.00 from $14.25-$15.25

TIPRANKS
·
Jul 29

Biogen Q2 Revenue USD 2,700 Million VS. Ibes Estimate USD 2,458 Million

THOMSON REUTERS
·
Jul 29

Biogen Cuts FY Adjusted View as 2Q Profit Declines

Dow Jones
·
Jul 29

Biogen Raises Earnings Guidance as Growth Portfolio Outpaces Legacy Blockbuster Drugs

Dow Jones
·
Jul 29

Biogen Q2 FY26 GAAP Diluted EPS Drops 85% to $0.66; Revenue Rises 3% to $2.74 Billion

Reuters
·
Jul 29

Biogen Q2 Leqembi Global in-Market Sales $184 Mln, up 15% YoY

THOMSON REUTERS
·
Jul 29

Biogen: Conversion to High-Dose Spinraza Regimen Ahead of Co's Expectations in All Launched Geographies

THOMSON REUTERS
·
Jul 29

Biogen Outlook FY REV Expected to Increase by Mid-Single Digit Percentage

THOMSON REUTERS
·
Jul 29

Biogen Q2 REV $2.74 Bln vs Ibes Estimate $2.46 Bln

THOMSON REUTERS
·
Jul 29

Biogen Outlook Expected Dilution from Apellis Deal on FY Adj EPS $-0.85

THOMSON REUTERS
·
Jul 29

Biogen price target raised to $200 from $185 at Barclays

TIPRANKS
·
Jul 29

Biogen beats estimates as new medicines overtake multiple sclerosis business

Robert Langreth / Bloomberg
·
Jul 29

U.S. Research ROUNDUP-Boeing, Coca-Cola, PayPal

Reuters
·
Jul 29

Biogen Inc. Stock Outperforms Competitors on Strong Trading Day

Dow Jones
·
Jul 29

Barclays Adjusts Biogen Price Target to $200 From $185, Maintains Equalweight Rating

MT Newswires Live
·
Jul 28

Biogen Inc. Stock Underperforms Monday When Compared to Competitors

Dow Jones
·
Jul 28